[Neurotrophic factors: basis for their clinical application]
- PMID: 12590377
[Neurotrophic factors: basis for their clinical application]
Abstract
Neurotrophic factors are molecules that regulate neuronal survival, nervous system plasticity and many other physiological functions of neuronal and glial cells, as well as some non-neuronal tissues. They have been involved in the etiopathogenesis of some neurodegenerative disorders, and some of them have been proposed as potential treatments for these diseases on the basis of in vitro experiments and animal models. The main neurotrophic factor families with potential therapeutic applications include the family of neurotrophins (NGF, BDNF or NT-3), GDNF and related neurotrophic factor, CNTF and the members of the IGF family. Some of these molecules have already been tested in clinical trials with contradictory results. One of the major challenges to their clinical use is the difficulty to deliver them into the central nervous system. Nevertheless, solid rational exists for the possible use of neurotrophic factors in the treatment of Alzheimer's and Parkinson's diseases, peripheral neuropathies or amyotrophic lateral sclerosis. This review compiles the essential aspects of neurotrophic factors and the current studies of their clinical relevance and therapeutic potentialities. Future directions for further research are also discussed.
Similar articles
-
Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.Ann N Y Acad Sci. 2007 Dec;1122:155-68. doi: 10.1196/annals.1403.011. Ann N Y Acad Sci. 2007. PMID: 18077571 Review.
-
[Possible relation of BDNF and GDNF to neuropsychiatric disorders].Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):85-9. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009. PMID: 19562947 Review. Japanese.
-
Clinical relevance of the neurotrophins and their receptors.Clin Sci (Lond). 2006 Feb;110(2):175-91. doi: 10.1042/CS20050161. Clin Sci (Lond). 2006. PMID: 16411894 Review.
-
Promoting neurotrophic effects by GPCR ligands.Novartis Found Symp. 2006;276:181-9; discussion 189-92, 233-7, 275-81. Novartis Found Symp. 2006. PMID: 16805430 Review.
-
SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases.Expert Opin Investig Drugs. 2009 Nov;18(11):1765-72. doi: 10.1517/13543780903329089. Expert Opin Investig Drugs. 2009. PMID: 19814656 Review.
Cited by
-
Translational models of stress and resilience: An applied neuroscience methodology review.Neurosci Appl. 2024 Apr 4;3:104064. doi: 10.1016/j.nsa.2024.104064. eCollection 2024. Neurosci Appl. 2024. PMID: 40656062 Free PMC article. Review.
-
Neurotrauma: The Crosstalk between Neurotrophins and Inflammation in the Acutely Injured Brain.Int J Mol Sci. 2017 May 18;18(5):1082. doi: 10.3390/ijms18051082. Int J Mol Sci. 2017. PMID: 28524074 Free PMC article. Review.
-
Downregulation of microRNA-124-3p promotes subventricular zone neural stem cell activation by enhancing the function of BDNF downstream pathways after traumatic brain injury in adult rats.CNS Neurosci Ther. 2022 Jul;28(7):1081-1092. doi: 10.1111/cns.13845. Epub 2022 Apr 28. CNS Neurosci Ther. 2022. PMID: 35481944 Free PMC article.
-
The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.Int J Mol Sci. 2023 Oct 11;24(20):15094. doi: 10.3390/ijms242015094. Int J Mol Sci. 2023. PMID: 37894774 Free PMC article.
-
Oligofructose alone and in combination with 2'fucosyllactose induces physiologically relevant changes in γ-aminobutyric acid and organic acid production compared to sole 2'fucosyllactose supplementation: an in vitro study.FEMS Microbiol Ecol. 2023 Aug 22;99(9):fiad100. doi: 10.1093/femsec/fiad100. FEMS Microbiol Ecol. 2023. PMID: 37653466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials